Mitsubishi UFJ Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-183,126	Closed	-$1.67M	–	1187
2022 Q1	$1.67M	Sell	183,126 -6,719	-4%	-$77.4K	0.01%	767
2021 Q4	$3.97M	Sell	189,845 -62,834	-25%	-$1.52M	0.02%	627
2021 Q3	$6.46M	Sell	252,679 -14,212	-5%	-$421K	0.03%	502
2021 Q2	$9.33M	Sell	266,891 -24,429	-8%	-$711K	0.05%	399
2021 Q1	$9.7M	Buy	291,320 +197,695	+211%	+$6.92M	0.06%	347
2020 Q4	$2.43M	Sell	93,625 -15,047	-14%	-$256K	0.02%	621
2020 Q3	$1.07M	Buy	108,672 +7,264	+7%	+$41.8K	0.01%	710
2020 Q2	$350K	Buy	101,408 +28,338	+39%	+$96.5K	﹤0.01%	803
2020 Q1	$224K	Buy	73,070 +3,017	+4%	+$12.4K	﹤0.01%	839
2019 Q4	$368K	Buy	70,053 +27,793	+66%	+$141K	﹤0.01%	810
2019 Q3	$218K	Buy	42,260 +886	+2%	+$4.96K	﹤0.01%	821
2019 Q2	$250K	Buy	41,374 +11,069	+37%	+$77.6K	﹤0.01%	806
2019 Q1	$219K	Buy	30,305 +733	+2%	+$5.3K	﹤0.01%	784
2018 Q4	$216K	Buy	+29,572	New	+$187K	0.01%	748